Cargando…
Subacute thyroiditis associated with COVID-19 infection: a report of an increasing entity
In March 2020, the World Health Organization characterized COVID-19 as a pandemic. By May 2021, 37 cases of subacute thyroiditis (SAT) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had been reported in the literature. We report a patient diagnosed with SAT associated w...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991023/ https://www.ncbi.nlm.nih.gov/pubmed/35263053 http://dx.doi.org/10.20945/2359-3997000000446 |
_version_ | 1784902055499923456 |
---|---|
author | Hajósi-Kalcakosz, Szofia Dénes, Judit Góth, Miklós |
author_facet | Hajósi-Kalcakosz, Szofia Dénes, Judit Góth, Miklós |
author_sort | Hajósi-Kalcakosz, Szofia |
collection | PubMed |
description | In March 2020, the World Health Organization characterized COVID-19 as a pandemic. By May 2021, 37 cases of subacute thyroiditis (SAT) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had been reported in the literature. We report a patient diagnosed with SAT associated with COVID-19 and review the previously reported cases. A 31-year-old female with no significant previous history developed SAT 5 weeks after SARS-CoV-2 infection. She presented with anterior neck pain and fever. Thyroid function tests revealed hyperthyroidism with slightly increased inflammatory markers. Thyroid ultrasound showed diffuse hypoechoic left lobe and a hypoechoic area in the right lobe. On the fine-needle-aspiration biopsy, large histiocytes, disrupted and normal follicles, and multinucleated giant cells within colloid were seen. Under oral corticosteroid therapy, clinical progression was rapid. Seven weeks later, all thyroid function tests and inflammatory markers normalized. During the recent viral outbreak, clinicians should keep in mind the possibility of SAT after COVID-19, and patients with symptoms of SAT should be tested for SARS-CoV-2. |
format | Online Article Text |
id | pubmed-9991023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Sociedade Brasileira de Endocrinologia e Metabologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-99910232023-03-14 Subacute thyroiditis associated with COVID-19 infection: a report of an increasing entity Hajósi-Kalcakosz, Szofia Dénes, Judit Góth, Miklós Arch Endocrinol Metab Case Report In March 2020, the World Health Organization characterized COVID-19 as a pandemic. By May 2021, 37 cases of subacute thyroiditis (SAT) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had been reported in the literature. We report a patient diagnosed with SAT associated with COVID-19 and review the previously reported cases. A 31-year-old female with no significant previous history developed SAT 5 weeks after SARS-CoV-2 infection. She presented with anterior neck pain and fever. Thyroid function tests revealed hyperthyroidism with slightly increased inflammatory markers. Thyroid ultrasound showed diffuse hypoechoic left lobe and a hypoechoic area in the right lobe. On the fine-needle-aspiration biopsy, large histiocytes, disrupted and normal follicles, and multinucleated giant cells within colloid were seen. Under oral corticosteroid therapy, clinical progression was rapid. Seven weeks later, all thyroid function tests and inflammatory markers normalized. During the recent viral outbreak, clinicians should keep in mind the possibility of SAT after COVID-19, and patients with symptoms of SAT should be tested for SARS-CoV-2. Sociedade Brasileira de Endocrinologia e Metabologia 2022-01-01 /pmc/articles/PMC9991023/ /pubmed/35263053 http://dx.doi.org/10.20945/2359-3997000000446 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Hajósi-Kalcakosz, Szofia Dénes, Judit Góth, Miklós Subacute thyroiditis associated with COVID-19 infection: a report of an increasing entity |
title | Subacute thyroiditis associated with COVID-19 infection: a report of an increasing entity |
title_full | Subacute thyroiditis associated with COVID-19 infection: a report of an increasing entity |
title_fullStr | Subacute thyroiditis associated with COVID-19 infection: a report of an increasing entity |
title_full_unstemmed | Subacute thyroiditis associated with COVID-19 infection: a report of an increasing entity |
title_short | Subacute thyroiditis associated with COVID-19 infection: a report of an increasing entity |
title_sort | subacute thyroiditis associated with covid-19 infection: a report of an increasing entity |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991023/ https://www.ncbi.nlm.nih.gov/pubmed/35263053 http://dx.doi.org/10.20945/2359-3997000000446 |
work_keys_str_mv | AT hajosikalcakoszszofia subacutethyroiditisassociatedwithcovid19infectionareportofanincreasingentity AT denesjudit subacutethyroiditisassociatedwithcovid19infectionareportofanincreasingentity AT gothmiklos subacutethyroiditisassociatedwithcovid19infectionareportofanincreasingentity |